QR kód

The effectiveness and safety of immune checkpoint inhibitors in conversion or neoadjuvant therapy for hepatocellular carcinoma: a meta-analysis and systematic review

Abstract Background The adoption of immune checkpoint inhibitors in combination with tyrosine kinase inhibitors (TKIs) and/or local therapy, including transarterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC), has been utilized as neoadjuvant or conversion therapy for...

Celý popis

Uloženo v:
Hlavní autoři: Lingbo Hu, Yongfu Xu, Yingli Qiao, Aidong Wang, Caidi He, Rongrong Wang
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2025-12-01
Edice:BMC Cancer
Témata:
Immune checkpoint inhibitors
Conversion therapy
Neoadjuvant therapy
Hepatocellular carcinoma
Liver resection
On-line přístup:https://doi.org/10.1186/s12885-025-15449-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky